Physician profile
Matthew Nettleman
NPI 1659756484
$2,858.00
in general payments reported to CMS, 2019-2025
36 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2020: $63.49 · 2021: $956 · 2022: $91.68 · 2023: $329 · 2024: $263 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $470.18 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $331.10 | 2019-2023 | Breztri |
| Lilly USA, LLC | $259.56 | 2019-2021 | |
| Pfizer INC. | $241.10 | 2019-2021 | |
| Abbott Laboratories | $199.32 | 2021-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $178.74 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.79 | 2019-2021 | |
| Amgen INC. | $109.60 | 2019-2021 | |
| Glaxosmithkline, LLC. | $102.99 | 2021-2023 | Shingrix, Arexvy |
| Dexcom, INC. | $99.95 | 2023-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $70.01 | 2021 | |
| Abbvie INC. | $59.27 | 2021 | |
| Amarin Pharma, INC. | $44.93 | 2019-2021 | |
| Inspire Medical Systems, INC. | $42.39 | 2023 | Inspire |
| Medtronic, INC. | $41.51 | 2024-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $38.05 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.73 | 2021 | |
| Novartis Pharmaceuticals Corporation | $33.69 | 2019 | |
| Grifols USA, LLC | $27.76 | 2023 | Prolastin-C Liquid |
| Biohaven Pharmaceuticals, INC. | $27.31 | 2021 | |
| Eisai INC. | $26.11 | 2019 | |
| Jazz Pharmaceuticals INC. | $24.92 | 2020 | |
| Medtronic Minimed, INC. | $22.31 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $21.03 | 2019 | |
| Boston Scientific Corporation | $19.31 | 2024 | |
| Allergan, INC. | $18.60 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.91 | 2021 | |
| Insulet Corporation | $16.13 | 2023 | Omnipod |
| Tactile Systems Technology INC | $14.62 | 2024 | Entre Plus, Flexitouch Plus |
| Sanofi-Aventis U.S. LLC | $13.26 | 2019 | |
| Almatica Pharma LLC | $13.23 | 2021 | |
| Astellas Pharma US INC | $12.95 | 2021 | |
| Merck Sharp & Dohme LLC | $12.44 | 2021 | |
| Avanir Pharmaceuticals, INC. | $12.33 | 2019 | |
| Shire North American Group INC | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Nettleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.